Drug Type Recombinant protein, Biosimilar |
Synonyms Recombinant Human Endostatin Biosimilar (Shanghai Hepu Pharmaceutical Co., Ltd.), 重组人血管内皮抑制素 生物类似药(上海贺普药业股份有限公司) |
Target |
Action antagonists |
Mechanism VEGFR antagonists(Vascular endothelial growth factor receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |

| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | China | - |






